combination therapy with glp-1 receptor agonist and sglt2 inhibitor Blood pressure effects of inhibitors GLP‐1 agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology Complementary Yet Distinct Roles of
Description
doi: 10.1056/NEJMoa2032183
Rev Diabet Stud 10(23):110120 Bunck MC, Cornr A, Eliasson B, Heine RJ, Shaginian RM, Wu Y et al (2010) One-year treatment with exenatide vs
The potent and reliable metabolic effects, coupled with ease of administration, make Ozempic the leading GLP-1 product globally, capturing the largest market share
doi: 10.1016/j.metabol.2019.154045
